CoLD Therapeutics receives Attractive Innovation Award
Helena Danielson, Jens Carlsson and Anja Sandström The award is given by UU Innovation to “innovative projects and startup companies that have successfully attracted external funds that further strengthen development opportunities”. The research team receives the award for having developed a group of new molecules that have the potential to be developed into an antiviral drug for the treatment of Covid-19.
The interdisciplinary collaboration behind CoLD Therapeutics includes Helena Danielson, Department of Chemistry-BMC, Jens Carlsson, Department of Cell and Molecular Biology, and Lindon Moodie and Anja Sandström, Department of Medicinal Chemistry.
Read the full article on Uppsala University's central website.